These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

678 related items for PubMed ID: 15068837

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
    Reddy BS, Hirose Y, Lubet R, Steele V, Kelloff G, Paulson S, Seibert K, Rao CV.
    Cancer Res; 2000 Jan 15; 60(2):293-7. PubMed ID: 10667579
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Coxibs: highly selective cyclooxygenase-2 inhibitors. Part I. Clinical efficacy].
    Burdan F, Korobowicz A.
    Pol Merkur Lekarski; 2003 Apr 15; 14(82):348-51. PubMed ID: 12868200
    [Abstract] [Full Text] [Related]

  • 8. [Coxibs: cyclooxygenase-2 inhibitors].
    Turnheim K.
    Wien Klin Wochenschr; 2001 Aug 16; 113(15-16):558-65. PubMed ID: 11571832
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Celecoxib exhibits the greatest potency amongst cyclooxygenase (COX) inhibitors for growth inhibition of COX-2-negative hematopoietic and epithelial cell lines.
    Waskewich C, Blumenthal RD, Li H, Stein R, Goldenberg DM, Burton J.
    Cancer Res; 2002 Apr 01; 62(7):2029-33. PubMed ID: 11929821
    [Abstract] [Full Text] [Related]

  • 13. [Clinical application of cyclooxygenase-2 inhibitors].
    Dzielska-Olczak M, Olczak S.
    Pol Merkur Lekarski; 2001 Jun 01; 10(60):480-2. PubMed ID: 11503270
    [Abstract] [Full Text] [Related]

  • 14. Celecoxib, a COX-2--specific inhibitor: the clinical data.
    Fort J.
    Am J Orthop (Belle Mead NJ); 1999 Mar 01; 28(3 Suppl):13-8. PubMed ID: 10193998
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Induction of apoptosis in rheumatoid synovial fibroblasts by celecoxib, but not by other selective cyclooxygenase 2 inhibitors.
    Kusunoki N, Yamazaki R, Kawai S.
    Arthritis Rheum; 2002 Dec 01; 46(12):3159-67. PubMed ID: 12483719
    [Abstract] [Full Text] [Related]

  • 17. Antiinflammatory and analgesic efficacy of COX-2 specific inhibition: from investigational trials to clinical experience.
    Bensen WG.
    J Rheumatol Suppl; 2000 Oct 01; 60():17-24. PubMed ID: 11032098
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Preferential COX-2 inhibition: its clinical relevance for gastrointestinal non-steroidal anti-inflammatory rheumatic drug toxicity].
    Dammann HG.
    Z Gastroenterol; 1999 Jan 01; 37(1):45-58. PubMed ID: 10091284
    [Abstract] [Full Text] [Related]

  • 20. Pain management in osteoarthritis: the role of COX-2 inhibitors.
    Lane NE.
    J Rheumatol Suppl; 1997 Jul 01; 49():20-4. PubMed ID: 9249647
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.